Review: Frailty Status May Predict Outcome After Cardiac Surgery

Share this content:
Review: Frailty Status May Predict Outcome After Cardiac Surgery
Review: Frailty Status May Predict Outcome After Cardiac Surgery

WEDNESDAY, Aug. 24, 2016 (HealthDay News) -- Frailty status may be able to predict outcome in older adults undergoing cardiac surgical procedures, although the quality of evidence is variable, according to a review published online Aug. 23 in the Annals of Internal Medicine.

Dae Hyun Kim, M.D., M.P.H., Sc.D., from Harvard Medical School in Boston, and colleagues examined the evidence for frailty instruments used to predict outcome in older adults undergoing cardiac surgical procedures.

The researchers found that nine frailty instruments were evaluated in 18,388 patients undergoing major procedures from eight studies. Moderate-quality evidence was used to assess mobility or disability, and very low- to low-quality evidence was used to predict mortality or major adverse cardiovascular and cerebrovascular events (MACCEs). None of the studies assessed functional status. Thirteen frailty instruments were assessed in 5,177 patients undergoing minimally invasive procedures in 17 studies. Moderate- to high-quality evidence was observed for assessing mobility to predict mortality or functional status. Mortality, functional status, or MACCEs were predicted in several multicomponent instruments, although the quality of evidence was low to moderate. Multicomponent instruments that assessed different domains outperformed single-component instruments.

"Frailty status, assessed by mobility, disability, and nutritional status, may predict mortality at six months or later after major cardiac surgical procedures and functional decline after minimally invasive cardiac surgery," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »